<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/086/SRR21124586/SRR21124586.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/082/SRR21124582/SRR21124582.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/092/SRR21124592/SRR21124592.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/085/SRR21124585/SRR21124585.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/090/SRR21124590/SRR21124590.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/088/SRR21124588/SRR21124588.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/084/SRR21124584/SRR21124584.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/091/SRR21124591/SRR21124591.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/083/SRR21124583/SRR21124583.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/087/SRR21124587/SRR21124587.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/093/SRR21124593/SRR21124593.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR211/089/SRR21124589/SRR21124589.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>UT Southwestern Medical Center</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA870904</full_dataset_link><scientific_name>Homo sapiens</scientific_name><long_description>We applied RiboLace, a novel method for the isolation of active ribosomes by means of an antibody-free and tag-free pull-down approach, to compare the active ribosome profiles of WT or eIF4E depleted HT1080 cells in normal and RSL3 treatment.</long_description><repository>ENA</repository></additional><is_claimable>false</is_claimable><name>Homo sapiens</name><description>Comparison of the translatome of WT or eIF4E depleted HT1080 cells in normal and RSL3 treatment</description><dates><last_updated>2025-09-24</last_updated><first_public>2022-10-11</first_public></dates><accession>PRJNA870904</accession><cross_references><taxon>9606</taxon></cross_references></HashMap>